Pregnancy Outcomes of Anti-Hypertensives for Women with Chronic Hypertension: A Population-Based Study

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Su, Chen Yi ^a   Lin, Herng Ching ^b   Cheng, Hsin Chung ^b,c   Yen, Amy Ming Fang ^b   Chen, Yi Hua ^b   Kao, Senyeong ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; VASODILATOR AGENT;

ADULT; ADVERSE OUTCOME; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INFANT; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; MATERNAL HYPERTENSION; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PREVALENCE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SMALL FOR DATE INFANT; CASE CONTROL STUDY; HYPERTENSION; NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREMATURE BIRTH; RISK; TAIWAN;

ADULT; ANTIHYPERTENSIVE AGENTS; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERTENSION; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; PREMATURE BIRTH; PREVALENCE; RISK; TAIWAN;

EID: 84873532178     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053844     Document Type: Article

References (37)

1. Magee LA, Ornstein MP, von Dadelszen P, (1999) Fortnightly review: management of hypertension in pregnancy. BMJ 318: 1332-1336.
2. Afifi Y, Churchill D, (2003) Pharmacological treatment of hypertension in pregnancy. Curr Pharm Des 9: 1745-1753.
3. Podymow T, August P, (2008) Update on the use of antihypertensive drugs in pregnancy. Hypertension 51: 960-969.
4. Magee LA, Duley L, (2003) Oral beta-blockers for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 3: CD002863.
5. Easterling TR, Carr DB, Brateng D, Diederichs C, Schmucker B, (2001) Treatment of hypertension in pregnancy: effect of atenolol on maternal disease, preterm delivery and fetal growth. Obstet Gynecol 98: 427-433.
6. Jannet D, Carbonne B, Sebban E, Milliez J, (1994) Nicardipine versus metoprolol in the treatment of hypertension during pregnancy: a randomized comparative trial. Obstet Gynecol 84: 354-359.
7. von Dadelszen P, Ornstein MP, Bull SB, Logan AG, Koren G, et al. (2000) Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet 355: 87-92.
8. Lennestål R, Otterblad Olausson P, Källén B, (2009) Maternal use of antihypertensive drugs in early pregnancy and delivery outcome, notably the presence of congenital heart defects in the infants. Eur J Clin Pharmacol 65: 615-625.
9. Weitz C, Khouzami V, Maxwell K, Johnson JW, (1987) Treatment of hypertension in pregnancy with methyldopa: a randomized double blind study. Int J Gynaecol Obstet 25: 35-40.
10. Sibai BM, Mabie WC, Shamsa F, Villar MA, Anderson GD, (1990) A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy. Am J Obstet Gynecol 162: 960-966.
11. Hanssens M, Keirse MJ, Vankelecom F, Van Assche FA, (1991) Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy. Obstet Gynecol 78: 128-135.
12. Abalos E, Duley L, Steyn DW, Henderson-Smart DJ, (2007) Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 1: CD002252.
13. Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, et al. (2006) Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 354: 2443-2451.
14. Li DK, Yang C, Andrade S, Tavares V, Ferber JR, (2011) Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study. BMJ 343: d5931.
15. Hsieh TT, Hsu JJ, Chen CJ, Chiu TH, Liou JD, et al. (1991) Analysis of birth weight andgestational age in Taiwan. J Formos Med Assoc 90: 382-387.
16. Heard AR, Dekker GA, Chan A, Jacobs DJ, Vreeburg SA, et al. (2004) Hypertension during pregnancy in south australia, part 1: pregnancy outcomes. Aust NZ J Obstet Gynaecol 44: 404-409.
17. Ananth CV, Peedicayil A, Savitz DA, (1995) Effect of hypertensive diseases in pregnancy on birthweight, gestational duration and small-for-gestational-age births. Epidemiology 6: 391-395.
18. Haelterman E, Bréart G, Paris-Llado J, Dramaix M, Tchobroutsky C, (1997) Effect of uncomplicated chronic hypertension on the risk of small-for-gestational age birth. Am J Epidemiol 145: 689-695.
19. Sibai BM, Caritis SN, Hauth JC, MacPherson C, VanDorsten JP, et al. (2000) Preterm delivery in women with pre-gestational diabetes mellitus or chronic hypertension relative to women with uncomplicated pregnancies. Am J Obstet Gynecol 183: 1520-1524.
20. Allen VM, Joseph K, Murphy KE, Magee LA, Ohlsson A, (2004) The effect of hypertensive disorders in pregnancy on small for gestational age and stillbirth: a population-based study. BMC Pregnancy Childbirth 4: 17.
21. Catov JM, Nohr EA, Olsen J, Ness RB, (2008) Chronic hypertension related to risk for preterm and term small for gestational age births. Obstet Gynecol 112: 290-296.
22. Lin HC, Lin HC, Chen SF, (2010) Increased risk of low birthweight and small for gestational age infants among women with tuberculosis. BJOG 117: 585-590.
23. Chen YH, Lin HC, Lin HC, (2010) Increased risk of adverse pregnancy outcomes among women affected by herpangina. Am J Obstet Gynecol 203: e1-e7.
24. Bell R, Glinianaia SV, Tennant PW, Bilous RW, Rankin J, (2012) Peri-conception hyperglycaemia and nephropathy are associated with risk of congenital anomaly in women with pre-existing diabetes: a population-based cohort study. Diabetologia 55: 936-947.
25. Ludford I, Scheil W, Tucker G, Grivell R, (2012) Pregnancy outcomes for nulliparous women of advanced maternal age in South Australia, 1998-2008. Aust N Z J Obstet Gynaecol 52: 235-241.
26. Chang C, Lu F, Yang YC, Wu JS, Wu TJ, et al. (2000) Epidemiologic study of type 2 diabetes in Taiwan. Diabetes Res Clin Pract 50: S49-S59.
27. Lee HC, Lin HC, (2010) Maternal bipolar disorder increased low birthweight and preterm births: a nationwide population-based study. J Affect Disord 121: 100-105.
28. Butters L, Kennedy S, Rubin PC, (1990) Atenolol in essential hypertension during pregnancy. BMJ 301: 587-589.
29. Lydakis C, Lip GY, Beevers M, Beevers DG, (1999) Atenolol and fetal growth in pregnancies complicated by hypertension. Am J Hypertens 12: 541-547.
30. Plouin PF, Bréart G, Llado J, Dalle M, Keller ME, et al. (1990) A randomized comparison of early with conservative use of antihypertensive drugs in the management of pregnancy-induced hypertension. Br J Obstet Gynaecol 97: 134-141.
31. Ray JG, Vermeulen MJ, Burrows EA, Burrows RF, (2001) Use of antihypertensive medications in pregnancy and the risk of adverse perinatal outcomes: McMaster outcome study of hypertension in pregnancy 2 (MOS HIP 2). BMC Pregnancy Childbirth 1: 6.
32. Constantine G, Beevers DG, Reynolds AL, Luesley DM, (1987) Nifedipine as a second line antihypertensive drug in pregnancy. Br J Obstet Gynaecol 94: 1136-1142.
33. Fenakel K, Fenakel G, Appelman Z, Lurie S, Katz Z, et al. (1991) Nifedipine in the treatment of severe preeclampsia. Obstet Gynecol 77: 331-337.
34. Olesen C, de Vries CS, Thrane N, MacDonald TM, Larsen H, et al. (2001) Effect of diuretics on fetal growth: a drug effect or confounding by indication? Pooled Danish and Scottish cohort data. Br J Clin Pharmacol 51: 153-157.
35. Rubin PC, Butters L, Clark DM, Reynolds B, Sumner DJ, et al. (1983) Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension. Lancet 1: 431-434.
36. Redman CW, (1976) Fetal outcome in trial of antihypertensive treatment in pregnancy. Lancet 2: 753-756.
37. Anonymous (1998) Nifedipine versus expectant management in mild to moderate hypertension in pregnancy. Br J Obstet Gynaecol 105: 718-722.